Safety and Efficacy of a Neonatal Fc Receptor Antagonist in Patients With Anti-NMDAR Encephalitis.

CNS Neurosci Ther · 2025 · PMC12336417 · PMID 40785430

Europe PMC DOI

hedged sentence

0.1160

closest p · 2.3× alpha

0.1160

boldest claim

The sentences

did not reach statistical significancep = 0.116not close (p > 0.1)

Although treatment with efgartigimod showed an apparent association with good prognosis, the result did not reach statistical significance (OR 6.35, 95% CI 0.77–102.80, p = 0.116), likely owing to the limited sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.